Experienced in Clear Cell Sarcoma

Helene Sudour-Bonnange

Lille, FR 
Experienced in Clear Cell Sarcoma
Lille, FR 
OverviewLocationsClinical Research

Overview

Helene Sudour-Bonnange practices in Lille, France. Ms. Sudour-Bonnange is rated as an Experienced expert by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are Wilms Tumor, Germ Cell Tumor, Febrile Neutropenia, Nephrectomy, and Vaginectomy.

Her clinical research consists of co-authoring 44 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Clear Cell Sarcoma.

Gender
Female

Locations

Lille, France
Other Locations
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2024
Intervention Type: Drug
Study Drugs: Cobimetinib, Atezolizumab
Study Phase: Phase 1/Phase 2
Review of the Paediatric Pleuropulmonary Blastoma French Series
Review of the Paediatric Pleuropulmonary Blastoma French Series
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Other
View 1 Less Clinical Trial

44 Total Publications

Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study group.
Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study group.
Journal: Urologic oncology
Published: January 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sudour-Bonnange's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile